1. Home
  2. IMMP vs CZNC Comparison

IMMP vs CZNC Comparison

Compare IMMP & CZNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • CZNC
  • Stock Information
  • Founded
  • IMMP 1987
  • CZNC 1864
  • Country
  • IMMP Australia
  • CZNC United States
  • Employees
  • IMMP N/A
  • CZNC N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • CZNC Major Banks
  • Sector
  • IMMP Health Care
  • CZNC Finance
  • Exchange
  • IMMP Nasdaq
  • CZNC Nasdaq
  • Market Cap
  • IMMP 251.8M
  • CZNC 301.8M
  • IPO Year
  • IMMP N/A
  • CZNC N/A
  • Fundamental
  • Price
  • IMMP $1.76
  • CZNC $20.49
  • Analyst Decision
  • IMMP Buy
  • CZNC
  • Analyst Count
  • IMMP 1
  • CZNC 0
  • Target Price
  • IMMP $7.00
  • CZNC N/A
  • AVG Volume (30 Days)
  • IMMP 79.3K
  • CZNC 51.8K
  • Earning Date
  • IMMP 10-21-2025
  • CZNC 08-08-2025
  • Dividend Yield
  • IMMP N/A
  • CZNC 5.47%
  • EPS Growth
  • IMMP N/A
  • CZNC 15.34
  • EPS
  • IMMP N/A
  • CZNC 1.75
  • Revenue
  • IMMP $3,019,249.00
  • CZNC $108,310,000.00
  • Revenue This Year
  • IMMP $50.37
  • CZNC $5.72
  • Revenue Next Year
  • IMMP N/A
  • CZNC $7.18
  • P/E Ratio
  • IMMP N/A
  • CZNC $11.74
  • Revenue Growth
  • IMMP 24.11
  • CZNC 4.96
  • 52 Week Low
  • IMMP $1.32
  • CZNC $17.85
  • 52 Week High
  • IMMP $2.72
  • CZNC $22.68
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 52.82
  • CZNC 65.59
  • Support Level
  • IMMP $1.63
  • CZNC $19.13
  • Resistance Level
  • IMMP $1.85
  • CZNC $19.84
  • Average True Range (ATR)
  • IMMP 0.07
  • CZNC 0.53
  • MACD
  • IMMP -0.01
  • CZNC 0.14
  • Stochastic Oscillator
  • IMMP 52.08
  • CZNC 100.00

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About CZNC Citizens & Northern Corp

Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.

Share on Social Networks: